HEADER HYDROLASE/HYDROLASE INHIBITOR 14-SEP-16 5GWY TITLE STRUCTURE OF MAIN PROTEASE FROM HUMAN CORONAVIRUS NL63: INSIGHTS FOR TITLE 2 WIDE SPECTRUM ANTI-CORONAVIRUS DRUG DESIGN COMPND MOL_ID: 1; COMPND 2 MOLECULE: MAIN PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3C-LIKE PROTEINASE; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~- COMPND 9 ((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3- COMPND 10 YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE; COMPND 11 CHAIN: D, E; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN CORONAVIRUS NL63; SOURCE 3 ORGANISM_COMMON: HCOV-NL63; SOURCE 4 ORGANISM_TAXID: 277944; SOURCE 5 GENE: 1A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS HCOV-NL63, MAIN PROTEASE, INHIBITOR, COMPLEX, DRUG DESIGN, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.WANG,C.CHEN,W.TAN,K.YANG,H.YANG REVDAT 4 15-NOV-23 5GWY 1 REMARK LINK ATOM REVDAT 3 08-NOV-23 5GWY 1 REMARK REVDAT 2 03-APR-19 5GWY 1 JRNL REVDAT 1 20-SEP-17 5GWY 0 JRNL AUTH F.WANG,C.CHEN,W.TAN,K.YANG,H.YANG JRNL TITL STRUCTURE OF MAIN PROTEASE FROM HUMAN CORONAVIRUS NL63: JRNL TITL 2 INSIGHTS FOR WIDE SPECTRUM ANTI-CORONAVIRUS DRUG DESIGN. JRNL REF SCI REP V. 6 22677 2016 JRNL REFN ESSN 2045-2322 JRNL PMID 26948040 JRNL DOI 10.1038/SREP22677 REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.48 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 19882 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.120 REMARK 3 FREE R VALUE TEST SET COUNT : 1018 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.4888 - 5.4523 1.00 2884 154 0.1963 0.2288 REMARK 3 2 5.4523 - 4.3287 1.00 2746 131 0.1663 0.2117 REMARK 3 3 4.3287 - 3.7818 1.00 2684 141 0.1788 0.2192 REMARK 3 4 3.7818 - 3.4361 1.00 2660 153 0.2103 0.2531 REMARK 3 5 3.4361 - 3.1899 1.00 2638 156 0.2103 0.2628 REMARK 3 6 3.1899 - 3.0019 1.00 2628 131 0.2283 0.2844 REMARK 3 7 3.0019 - 2.8516 0.99 2624 152 0.2465 0.3170 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.650 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 4781 REMARK 3 ANGLE : 1.335 6496 REMARK 3 CHIRALITY : 0.051 732 REMARK 3 PLANARITY : 0.004 828 REMARK 3 DIHEDRAL : 18.421 1644 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5GWY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-SEP-16. REMARK 100 THE DEPOSITION ID IS D_1300001612. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BSRF REMARK 200 BEAMLINE : 1W2B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19967 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.850 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 14.20 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3TLO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CITRATE TRIBASIC REMARK 280 DIHYDRATE, 1.0 M AMMONIUM PHOSPHATE MONOBASIE, PH 5.6, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 106.03050 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.62750 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.62750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 53.01525 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.62750 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.62750 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 159.04575 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.62750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.62750 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 53.01525 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.62750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.62750 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 159.04575 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 106.03050 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)- REMARK 400 4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL) REMARK 400 -L-LEUCINAMIDE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R, REMARK 400 2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL] REMARK 400 METHYL}BUT-2-ENYL)-L-LEUCINAMIDE REMARK 400 CHAIN: D, E REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 SER A 1 REMARK 465 GLY A 2 REMARK 465 ASN A 301 REMARK 465 LEU A 302 REMARK 465 GLN A 303 REMARK 465 GLY B -4 REMARK 465 PRO B -3 REMARK 465 GLN B 303 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLN A 192 CA CB CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN A 261 O HOH A 401 1.80 REMARK 500 O HOH B 499 O HOH B 507 1.81 REMARK 500 O CYS A 247 O HOH A 402 1.82 REMARK 500 O LYS B 276 O HOH B 401 1.84 REMARK 500 NZ LYS B 4 O HOH B 402 1.87 REMARK 500 O LEU A 263 O HOH A 403 1.87 REMARK 500 O PJE E 5 O HOH E 101 1.90 REMARK 500 O HOH B 536 O HOH B 541 1.90 REMARK 500 OG SER B 1 O HOH B 403 1.91 REMARK 500 OE1 GLU B 118 O HOH B 404 1.93 REMARK 500 O THR A 240 O HOH A 404 1.94 REMARK 500 OD1 ASN B 184 O HOH B 405 1.97 REMARK 500 O HOH B 449 O HOH B 542 1.97 REMARK 500 O HOH A 495 O HOH A 507 1.98 REMARK 500 O HOH A 469 O HOH A 492 1.99 REMARK 500 O HOH B 513 O HOH B 541 2.00 REMARK 500 NH2 ARG B 224 O HOH B 406 2.00 REMARK 500 O HOH A 536 O HOH B 527 2.00 REMARK 500 ND2 ASN A 141 O HOH A 405 2.01 REMARK 500 O PJE D 5 O HOH D 101 2.02 REMARK 500 O HOH A 531 O HOH A 537 2.03 REMARK 500 O HOH A 417 O HOH A 464 2.04 REMARK 500 SG CYS A 144 C21 PJE E 5 2.04 REMARK 500 OH TYR B 117 O HOH B 407 2.04 REMARK 500 OG SER A 201 O HOH A 404 2.05 REMARK 500 O GLY B 142 O HOH B 408 2.05 REMARK 500 O HOH B 516 O HOH B 519 2.06 REMARK 500 O HOH B 497 O HOH B 504 2.06 REMARK 500 OD2 ASP B 154 O HOH B 409 2.07 REMARK 500 NZ LYS A 136 O HOH A 406 2.09 REMARK 500 O ALA A 196 O HOH A 407 2.09 REMARK 500 O HOH A 544 O HOH B 545 2.09 REMARK 500 O HOH B 476 O HOH B 537 2.12 REMARK 500 O HOH B 495 O HOH B 514 2.12 REMARK 500 O HOH B 520 O HOH B 546 2.12 REMARK 500 O HOH A 518 O HOH B 480 2.12 REMARK 500 N GLN A 267 O HOH A 403 2.13 REMARK 500 O HOH B 460 O HOH B 521 2.13 REMARK 500 OE2 GLU A 271 O HOH A 408 2.14 REMARK 500 O HOH A 494 O HOH B 528 2.14 REMARK 500 NH2 ARG A 15 O HOH A 409 2.14 REMARK 500 O HOH B 534 O HOH B 535 2.14 REMARK 500 O HIS B 63 O HOH B 410 2.14 REMARK 500 O HOH A 471 O HOH A 513 2.14 REMARK 500 O ALA B 44 O HOH B 411 2.15 REMARK 500 O HOH A 402 O HOH A 447 2.15 REMARK 500 O HOH A 528 O HOH A 544 2.16 REMARK 500 O HOH B 498 O HOH B 540 2.18 REMARK 500 O LEU A 262 O HOH A 410 2.18 REMARK 500 N ILE A 266 O HOH A 410 2.18 REMARK 500 REMARK 500 THIS ENTRY HAS 56 CLOSE CONTACTS REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 535 O HOH B 436 3555 2.05 REMARK 500 O HOH A 475 O HOH B 494 3555 2.09 REMARK 500 O HOH A 516 O HOH B 529 6554 2.10 REMARK 500 O HOH B 421 O HOH B 473 6454 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 140 -162.80 -129.78 REMARK 500 GLN A 164 -44.97 -134.67 REMARK 500 PRO A 189 35.93 -78.05 REMARK 500 SER A 244 56.40 -157.65 REMARK 500 VAL A 245 -47.18 79.46 REMARK 500 SER B 0 175.31 176.32 REMARK 500 GLN B 164 -42.10 -135.90 REMARK 500 PRO B 189 35.43 -77.04 REMARK 500 SER B 244 54.26 -157.03 REMARK 500 GLU B 246 -10.83 -146.23 REMARK 500 LYS B 276 172.45 -56.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF N-[(5-METHYLISOXAZOL REMARK 800 -3-YL)CARBONYL]ALANYL-L-VALYL-N~1~- ((1R,2Z)-4-(BENZYLOXY)-4-OXO- REMARK 800 1-{[(3R)-2-OXOPYRROLIDIN-3- YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF N-[(5-METHYLISOXAZOL REMARK 800 -3-YL)CARBONYL]ALANYL-L-VALYL-N~1~- ((1R,2Z)-4-(BENZYLOXY)-4-OXO- REMARK 800 1-{[(3R)-2-OXOPYRROLIDIN-3- YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE DBREF 5GWY A 1 303 UNP P0C6U6 R1A_CVHNL 2940 3242 DBREF 5GWY B 1 303 UNP P0C6U6 R1A_CVHNL 2940 3242 DBREF 5GWY D 1 6 PDB 5GWY 5GWY 1 6 DBREF 5GWY E 1 6 PDB 5GWY 5GWY 1 6 SEQADV 5GWY GLY A -4 UNP P0C6U6 EXPRESSION TAG SEQADV 5GWY PRO A -3 UNP P0C6U6 EXPRESSION TAG SEQADV 5GWY LEU A -2 UNP P0C6U6 EXPRESSION TAG SEQADV 5GWY GLY A -1 UNP P0C6U6 EXPRESSION TAG SEQADV 5GWY SER A 0 UNP P0C6U6 EXPRESSION TAG SEQADV 5GWY GLY B -4 UNP P0C6U6 EXPRESSION TAG SEQADV 5GWY PRO B -3 UNP P0C6U6 EXPRESSION TAG SEQADV 5GWY LEU B -2 UNP P0C6U6 EXPRESSION TAG SEQADV 5GWY GLY B -1 UNP P0C6U6 EXPRESSION TAG SEQADV 5GWY SER B 0 UNP P0C6U6 EXPRESSION TAG SEQRES 1 A 308 GLY PRO LEU GLY SER SER GLY LEU LYS LYS MET ALA GLN SEQRES 2 A 308 PRO SER GLY CYS VAL GLU ARG CYS VAL VAL ARG VAL CYS SEQRES 3 A 308 TYR GLY SER THR VAL LEU ASN GLY VAL TRP LEU GLY ASP SEQRES 4 A 308 THR VAL THR CYS PRO ARG HIS VAL ILE ALA PRO SER THR SEQRES 5 A 308 THR VAL LEU ILE ASP TYR ASP HIS ALA TYR SER THR MET SEQRES 6 A 308 ARG LEU HIS ASN PHE SER VAL SER HIS ASN GLY VAL PHE SEQRES 7 A 308 LEU GLY VAL VAL GLY VAL THR MET HIS GLY SER VAL LEU SEQRES 8 A 308 ARG ILE LYS VAL SER GLN SER ASN VAL HIS THR PRO LYS SEQRES 9 A 308 HIS VAL PHE LYS THR LEU LYS PRO GLY ASP SER PHE ASN SEQRES 10 A 308 ILE LEU ALA CYS TYR GLU GLY ILE ALA SER GLY VAL PHE SEQRES 11 A 308 GLY VAL ASN LEU ARG THR ASN PHE THR ILE LYS GLY SER SEQRES 12 A 308 PHE ILE ASN GLY ALA CYS GLY SER PRO GLY TYR ASN VAL SEQRES 13 A 308 ARG ASN ASP GLY THR VAL GLU PHE CYS TYR LEU HIS GLN SEQRES 14 A 308 ILE GLU LEU GLY SER GLY ALA HIS VAL GLY SER ASP PHE SEQRES 15 A 308 THR GLY SER VAL TYR GLY ASN PHE ASP ASP GLN PRO SER SEQRES 16 A 308 LEU GLN VAL GLU SER ALA ASN LEU MET LEU SER ASP ASN SEQRES 17 A 308 VAL VAL ALA PHE LEU TYR ALA ALA LEU LEU ASN GLY CYS SEQRES 18 A 308 ARG TRP TRP LEU CYS SER THR ARG VAL ASN VAL ASP GLY SEQRES 19 A 308 PHE ASN GLU TRP ALA MET ALA ASN GLY TYR THR SER VAL SEQRES 20 A 308 SER SER VAL GLU CYS TYR SER ILE LEU ALA ALA LYS THR SEQRES 21 A 308 GLY VAL SER VAL GLU GLN LEU LEU ALA SER ILE GLN HIS SEQRES 22 A 308 LEU HIS GLU GLY PHE GLY GLY LYS ASN ILE LEU GLY TYR SEQRES 23 A 308 SER SER LEU CYS ASP GLU PHE THR LEU ALA GLU VAL VAL SEQRES 24 A 308 LYS GLN MET TYR GLY VAL ASN LEU GLN SEQRES 1 B 308 GLY PRO LEU GLY SER SER GLY LEU LYS LYS MET ALA GLN SEQRES 2 B 308 PRO SER GLY CYS VAL GLU ARG CYS VAL VAL ARG VAL CYS SEQRES 3 B 308 TYR GLY SER THR VAL LEU ASN GLY VAL TRP LEU GLY ASP SEQRES 4 B 308 THR VAL THR CYS PRO ARG HIS VAL ILE ALA PRO SER THR SEQRES 5 B 308 THR VAL LEU ILE ASP TYR ASP HIS ALA TYR SER THR MET SEQRES 6 B 308 ARG LEU HIS ASN PHE SER VAL SER HIS ASN GLY VAL PHE SEQRES 7 B 308 LEU GLY VAL VAL GLY VAL THR MET HIS GLY SER VAL LEU SEQRES 8 B 308 ARG ILE LYS VAL SER GLN SER ASN VAL HIS THR PRO LYS SEQRES 9 B 308 HIS VAL PHE LYS THR LEU LYS PRO GLY ASP SER PHE ASN SEQRES 10 B 308 ILE LEU ALA CYS TYR GLU GLY ILE ALA SER GLY VAL PHE SEQRES 11 B 308 GLY VAL ASN LEU ARG THR ASN PHE THR ILE LYS GLY SER SEQRES 12 B 308 PHE ILE ASN GLY ALA CYS GLY SER PRO GLY TYR ASN VAL SEQRES 13 B 308 ARG ASN ASP GLY THR VAL GLU PHE CYS TYR LEU HIS GLN SEQRES 14 B 308 ILE GLU LEU GLY SER GLY ALA HIS VAL GLY SER ASP PHE SEQRES 15 B 308 THR GLY SER VAL TYR GLY ASN PHE ASP ASP GLN PRO SER SEQRES 16 B 308 LEU GLN VAL GLU SER ALA ASN LEU MET LEU SER ASP ASN SEQRES 17 B 308 VAL VAL ALA PHE LEU TYR ALA ALA LEU LEU ASN GLY CYS SEQRES 18 B 308 ARG TRP TRP LEU CYS SER THR ARG VAL ASN VAL ASP GLY SEQRES 19 B 308 PHE ASN GLU TRP ALA MET ALA ASN GLY TYR THR SER VAL SEQRES 20 B 308 SER SER VAL GLU CYS TYR SER ILE LEU ALA ALA LYS THR SEQRES 21 B 308 GLY VAL SER VAL GLU GLN LEU LEU ALA SER ILE GLN HIS SEQRES 22 B 308 LEU HIS GLU GLY PHE GLY GLY LYS ASN ILE LEU GLY TYR SEQRES 23 B 308 SER SER LEU CYS ASP GLU PHE THR LEU ALA GLU VAL VAL SEQRES 24 B 308 LYS GLN MET TYR GLY VAL ASN LEU GLN SEQRES 1 D 6 02J ALA VAL LEU PJE 010 SEQRES 1 E 6 02J ALA VAL LEU PJE 010 HET 02J D 1 8 HET PJE D 5 13 HET 010 D 6 8 HET 02J E 1 8 HET PJE E 5 13 HET 010 E 6 8 HETNAM 02J 5-METHYL-1,2-OXAZOLE-3-CARBOXYLIC ACID HETNAM PJE (E,4S)-4-AZANYL-5-[(3S)-2-OXIDANYLIDENEPYRROLIDIN-3- HETNAM 2 PJE YL]PENT-2-ENOIC ACID HETNAM 010 PHENYLMETHANOL FORMUL 3 02J 2(C5 H5 N O3) FORMUL 3 PJE 2(C9 H14 N2 O3) FORMUL 3 010 2(C7 H8 O) FORMUL 5 HOH *295(H2 O) HELIX 1 AA1 SER A 10 ARG A 15 1 6 HELIX 2 AA2 HIS A 41 ALA A 44 5 4 HELIX 3 AA3 ASP A 52 THR A 59 1 8 HELIX 4 AA4 ARG A 61 HIS A 63 5 3 HELIX 5 AA5 VAL A 181 PHE A 185 5 5 HELIX 6 AA6 LEU A 200 ASN A 214 1 15 HELIX 7 AA7 ASN A 226 MET A 235 1 10 HELIX 8 AA8 VAL A 245 CYS A 247 5 3 HELIX 9 AA9 TYR A 248 GLY A 256 1 9 HELIX 10 AB1 SER A 258 GLY A 272 1 15 HELIX 11 AB2 THR A 289 GLY A 299 1 11 HELIX 12 AB3 SER B 10 ARG B 15 1 6 HELIX 13 AB4 HIS B 41 ALA B 44 5 4 HELIX 14 AB5 ASP B 52 THR B 59 1 8 HELIX 15 AB6 ARG B 61 HIS B 63 5 3 HELIX 16 AB7 VAL B 181 PHE B 185 5 5 HELIX 17 AB8 LEU B 200 ASN B 214 1 15 HELIX 18 AB9 ASN B 226 MET B 235 1 10 HELIX 19 AC1 TYR B 248 GLY B 256 1 9 HELIX 20 AC2 SER B 258 GLU B 271 1 14 HELIX 21 AC3 THR B 289 GLY B 299 1 11 SHEET 1 AA1 7 VAL A 72 LEU A 74 0 SHEET 2 AA1 7 PHE A 65 HIS A 69 -1 N VAL A 67 O LEU A 74 SHEET 3 AA1 7 VAL A 17 TYR A 22 -1 N ARG A 19 O SER A 68 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O THR A 25 N TYR A 22 SHEET 5 AA1 7 THR A 35 PRO A 39 -1 O THR A 35 N LEU A 32 SHEET 6 AA1 7 VAL A 85 VAL A 90 -1 O ILE A 88 N VAL A 36 SHEET 7 AA1 7 VAL A 76 HIS A 82 -1 N GLY A 78 O LYS A 89 SHEET 1 AA2 5 HIS A 100 PHE A 102 0 SHEET 2 AA2 5 VAL A 157 GLU A 166 1 O PHE A 159 N VAL A 101 SHEET 3 AA2 5 PRO A 147 VAL A 151 -1 N ASN A 150 O GLU A 158 SHEET 4 AA2 5 SER A 110 TYR A 117 -1 N LEU A 114 O PRO A 147 SHEET 5 AA2 5 ILE A 120 ASN A 128 -1 O SER A 122 N ALA A 115 SHEET 1 AA3 3 HIS A 100 PHE A 102 0 SHEET 2 AA3 3 VAL A 157 GLU A 166 1 O PHE A 159 N VAL A 101 SHEET 3 AA3 3 HIS A 172 SER A 175 -1 O VAL A 173 N ILE A 165 SHEET 1 AA4 7 VAL B 72 LEU B 74 0 SHEET 2 AA4 7 PHE B 65 HIS B 69 -1 N VAL B 67 O LEU B 74 SHEET 3 AA4 7 VAL B 17 TYR B 22 -1 N ARG B 19 O SER B 68 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 AA4 7 THR B 35 PRO B 39 -1 O THR B 37 N VAL B 30 SHEET 6 AA4 7 VAL B 85 VAL B 90 -1 O ILE B 88 N VAL B 36 SHEET 7 AA4 7 VAL B 76 HIS B 82 -1 N VAL B 77 O LYS B 89 SHEET 1 AA5 5 HIS B 100 PHE B 102 0 SHEET 2 AA5 5 VAL B 157 GLU B 166 1 O PHE B 159 N VAL B 101 SHEET 3 AA5 5 PRO B 147 VAL B 151 -1 N ASN B 150 O GLU B 158 SHEET 4 AA5 5 SER B 110 TYR B 117 -1 N LEU B 114 O PRO B 147 SHEET 5 AA5 5 ILE B 120 ASN B 128 -1 O PHE B 125 N ILE B 113 SHEET 1 AA6 3 HIS B 100 PHE B 102 0 SHEET 2 AA6 3 VAL B 157 GLU B 166 1 O PHE B 159 N VAL B 101 SHEET 3 AA6 3 HIS B 172 SER B 175 -1 O VAL B 173 N ILE B 165 LINK SG CYS A 144 C20 PJE E 5 1555 1555 1.80 LINK SG CYS B 144 C20 PJE D 5 1555 1555 1.80 LINK C 02J D 1 N ALA D 2 1555 1555 1.44 LINK C LEU D 4 N PJE D 5 1555 1555 1.45 LINK C PJE D 5 O 010 D 6 1555 1555 1.42 LINK C 02J E 1 N ALA E 2 1555 1555 1.43 LINK C LEU E 4 N PJE E 5 1555 1555 1.43 LINK C PJE E 5 O 010 E 6 1555 1555 1.41 CISPEP 1 SER A 243 SER A 244 0 -5.69 CISPEP 2 SER B 243 SER B 244 0 3.19 SITE 1 AC1 23 SER B 1 THR B 25 VAL B 26 THR B 47 SITE 2 AC1 23 ILE B 51 PHE B 139 GLY B 142 CYS B 144 SITE 3 AC1 23 HIS B 163 GLN B 164 ILE B 165 GLU B 166 SITE 4 AC1 23 GLY B 168 HIS B 172 PRO B 189 SER B 190 SITE 5 AC1 23 LEU B 191 LYS B 254 MET B 297 HOH B 444 SITE 6 AC1 23 HOH B 446 HOH B 461 HOH D 101 SITE 1 AC2 21 VAL A 26 LEU A 27 HIS A 41 PHE A 139 SITE 2 AC2 21 GLY A 142 CYS A 144 HIS A 163 GLN A 164 SITE 3 AC2 21 ILE A 165 GLU A 166 GLY A 168 ASP A 187 SITE 4 AC2 21 PRO A 189 SER A 190 LEU A 191 HOH A 522 SITE 5 AC2 21 LEU B -2 LEU B 191 GLU B 194 HOH E 101 SITE 6 AC2 21 HOH E 102 CRYST1 87.255 87.255 212.061 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011461 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011461 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004716 0.00000